Back to UCLA Medical Center Hematology and Medical Oncology
Daniel Cancilla
Hematology and Medical Oncology Fellow · UCLA David Geffen School of Medicine/UCLA Medical Center
Credentials: · · ·
History
- 2022–2025
Internal Medicine
2022–2023
Research
eLife · 2020 · 133 citations
Targeting CXCR4 in AML and ALL
Review · Frontiers in Oncology · 2020 · First of 3 authors · 86 citations
Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells
Journal of Clinical Investigation · 2019 · 40 citations
3 papers
2 papers
2 papers
2 papers
1 paper
1 paper
1 paper
1 paper
